Conference Calendar

March 14-18 - American Association of Orthopaedic Medicine Annual Meeting 2017

March 14-December 31 - Canaccord Genuity Musculoskeletal Conference

Complete Calendar »

Earnings Calendar

No Upcoming Events Scheduled
Complete Calendar »

Read our research via:
email art

Weekly Email

rss art

RSS



app icon

iPhone

app store icon

Kindle



Orthopedic and Dental Industry News

September 2007

Musculoskeletal News Roundup 28-Sept-07 BY LAUREN UZDIENSKI, SEPTEMBER 28, 2007

Legal Federal prosecutors announced on Thursday the terms of a settlement with Zimmer, Depuy, Biomet, Smith & Nephew and Stryker following an investigation into physician compensation practices. Zimmer, Depuy, Biomet and Smith & Nephew entered into deferred prosecution agreements and... more

Zimmer, Depuy, Biomet, Smith & Nephew and Stryker Settle DOJ Investigation for $311 million BY LAUREN UZDIENSKI, SEPTEMBER 27, 2007

Federal prosecutors announced today the terms of a settlement with Zimmer, Depuy, Biomet, Smith & Nephew and Stryker following an investigation into physician kickbacks. Zimmer, Depuy, Biomet and Smith & Nephew entered into deferred prosecution agreements (where a company can... more

Alphatec Holdings, Inc. Announces Exercise of Option to Purchase Additional Shares BY EDITOR, SEPTEMBER 26, 2007

CARLSBAD, Calif., Sep 25, 2007 -- Alphatec Holdings, Inc. (Nasdaq:ATEC), a medical technology company focused on the design, development, manufacturing and marketing of products for the surgical treatment of spine disorders, announced that Canaccord Adams Inc., the sole underwriter of... more

FDA Throws ReGen Biologics Another Curveball BY DAVID KRESSEL, SEPTEMBER 25, 2007

ReGen Biologics today announced it received a "Not Substantially Equivalent" (NSE) letter from the FDA in response to the 510(k) premarket notification the company submitted for its meniscal repair implant. In a press release and conference call, a clearly frustrated... more

Alphatec Holdings, Inc. Announces Pricing of Common Stock Offering BY EDITOR, SEPTEMBER 23, 2007

CARLSBAD, Calif., Sep 21, 2007 -- Alphatec Holdings, Inc. (Nasdaq:ATEC), a medical technology company focused on the design, development, manufacturing and marketing of products for the surgical treatment of spine disorders, announced the pricing of its public offering of 8,800,000... more

Musculoskeletal News Roundup 20-Sept-07 BY LAUREN UZDIENSKI, SEPTEMBER 18, 2007

Earnings AOI Medical reported a 1H:07 loss of $1.8 million, increasing from a loss of $0.97 million in the comparable half. The company attributed the loss to increased expenses. They expect their product, the Balloon Assisted Management of Spine Fractures,... more

Pill Reduces Risk of Blood Clots After Hip Replacement BY LAUREN UZDIENSKI, SEPTEMBER 18, 2007

As published in the Lancet this week, results of a new trial showed that a pill called dabigatran etexilate (DE) was as effective as the injected drug enoxaparin in reducing the risk of blood clots following total hip replacement. DE... more

HealthpointCapital Interviews Dr. J. Kevin McGraw: A Look into Spine Interventional Radiology BY ARIELLA P. GOLOMB, MD, SEPTEMBER 17, 2007

J. Kevin McGraw, MD, FSIR is the Co-Director of Vascular and Interventional Radiology Riverside Methodist Hospital in Columbus, Ohio and a Clinical Assistant Professor of Radiology at the Medical College of Ohio in Toledo, Ohio. He currently serves on... more

Alphatec Holdings, Inc. Acquires An Exclusive Worldwide License for Technology Related to Guided Lumbar Interbody Fusion System BY EDITOR, SEPTEMBER 14, 2007

Alphatec Holdings, Inc. (Nasdaq:ATEC), a medical technology company focused on the design, development, manufacturing and marketing of products for the surgical treatment of spine disorders, announced the entry into an exclusive worldwide license for a unique minimally invasive guided lumbar... more

Alphatec Holdings, Inc. Names Veteran Marketing Executive Kathryn Liljestrand as Vice President of Marketing BY EDITOR, SEPTEMBER 14, 2007

Alphatec Holdings, Inc. (Nasdaq:ATEC), a medical technology company focused on the design, development, manufacturing and marketing of products for the surgical treatment of spine disorders, announced today that veteran marketing executive, Kathryn Liljestrand, has joined the company as Vice President... more

Musculoskeletal News Roundup 13-Sept-07 BY LAUREN UZDIENSKI, SEPTEMBER 13, 2007

M&A Medtronic and Kyphon announced that the FTC and the U.S. Department of Justice antitrust division granted early termination of the waiting period for the companies' merger. Additional antitrust authorities must still approve the transaction, which is expected to close... more

Alphatec Holdings, Inc. Acquires an Exclusive Worldwide License for Vertebroplasty Technology System Focused on Solutions for Vertebral Compression Fractures BY EDITOR, SEPTEMBER 12, 2007

Alphatec Holdings, Inc. (NASDAQ: ATEC), a medical technology company focused on the design, development, manufacturing and marketing of products for the surgical treatment of spine disorders, announced the entry into an exclusive worldwide license for a unique vertebroplasty technology system... more

Alphatec Holdings, Inc. Announces Proposed Public Offering of Common Stock BY EDITOR, SEPTEMBER 12, 2007

Alphatec Holdings, Inc. (Nasdaq:ATEC), a medical technology company focused on the design, development, manufacturing and marketing of products for the surgical treatment of spine disorders, announced plans to offer 8,000,000 shares of common stock pursuant to an effective registration statement... more

Alphatec Holdings, Inc. Names Veteran Operations Executive Kermit P. Stott as Vice President of Operations BY EDITOR, SEPTEMBER 12, 2007

Alphatec Holdings, Inc. (Nasdaq:ATEC), a leading medical technology company focused on the design, development, manufacturing and marketing of products for the surgical treatment of spine disorders, announced today that veteran operations executive, Kermit Stott, has joined the company as Vice... more

JBJS: U.K. NICE Guidelines Have "Little Impact" on Surgeons' Product Selection BY LAUREN UZDIENSKI, SEPTEMBER 10, 2007

The July U.K. edition of JBJS reported results of a study evaluating the impact of the U.K.'s National Institute for Health and Clinical Excellence (NICE) guidelines for hip replacements. NICE publishes guidelines to promote "good health and the prevention and... more

Army Advancing Prosthetics BY DAVID KRESSEL, SEPTEMBER 7, 2007

At the confluence of war and improved medical care sit the 130 U.S. veterans of the current war in Iraq who have had an arm amputated. Advances in battlefield medical care have allowed soldiers who would have died in combat... more

Musculoskeletal News Roundup 6-Sept-07 BY LAUREN UZDIENSKI, SEPTEMBER 6, 2007

Regulatory Inion Oy received FDA approval for its implant material BioRestore in dental and cranio-maxillofacial applications. The product is designed to fill bony voids or gaps in the skeleton. BioRestore is currently being reviewed by the FDA for use in... more

Biomet Shareholders Approve Private Equity Transaction BY ARIELLA P. GOLOMB, MD, SEPTEMBER 5, 2007

Yesterday afternoon Biomet announced that its acquisition by a private equity consortium was approved by the Company's shareholders at the increased price of $46.00 per share. According to a preliminary tally, 91.56% of the total shares outstanding voted in favor... more

Medtronic to Market the Prestige Disc to Hispanics BY LAUREN UZDIENSKI, SEPTEMBER 5, 2007

Following recent FDA approval of its Prestige artificial cervical disc, Medtronic announced the launch of a new advertising campaign aimed at Hispanics. The campaign, which was announced in a press release, features a Spanish-language website. In the press release, Dr.... more


Complete Archive